Tom Hofste

1.7k total citations
10 papers, 172 citations indexed

About

Tom Hofste is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Tom Hofste has authored 10 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Tom Hofste's work include Cancer Genomics and Diagnostics (4 papers), Mitochondrial Function and Pathology (3 papers) and Genomics and Rare Diseases (2 papers). Tom Hofste is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Mitochondrial Function and Pathology (3 papers) and Genomics and Rare Diseases (2 papers). Tom Hofste collaborates with scholars based in Netherlands, Germany and United States. Tom Hofste's co-authors include Leo Nijtmans, Mohammed Ghiath Shamdeen, A.J.M. Janssen, Richard J. Rodenburg, Jan Smeıtınk, Marije Hogeveen, Ulrich Dillmann, Frans A. Hol, An I. Jonckheere and Livia Kapusta and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Scientific Reports and Journal of Medical Genetics.

In The Last Decade

Tom Hofste

8 papers receiving 169 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Hofste Netherlands 7 119 54 26 24 18 10 172
Esmeralda Rodrigues Portugal 9 112 0.9× 102 1.9× 8 0.3× 21 0.9× 20 1.1× 26 199
Masaki Wake Japan 4 104 0.9× 13 0.2× 39 1.5× 76 3.2× 14 0.8× 7 171
Aisha Al Shamsi United Arab Emirates 6 67 0.6× 18 0.3× 9 0.3× 35 1.5× 11 0.6× 13 129
Matthias Kettwig Germany 6 75 0.6× 15 0.3× 10 0.4× 18 0.8× 22 1.2× 10 138
Ping Chun Wu United States 5 91 0.8× 41 0.8× 8 0.3× 24 1.0× 6 0.3× 8 171
Anna Barbara Mancuso Italy 4 80 0.7× 8 0.1× 13 0.5× 26 1.1× 12 0.7× 4 119
Caroline Scholz Germany 6 86 0.7× 14 0.3× 15 0.6× 62 2.6× 3 0.2× 8 127
Yael Wilnai United States 6 94 0.8× 37 0.7× 13 0.5× 85 3.5× 10 0.6× 10 176
Laura Benedetta Amato Italy 7 110 0.9× 13 0.2× 61 2.3× 21 0.9× 5 0.3× 10 149
Gudny A. Arnadottir Iceland 5 47 0.4× 8 0.1× 25 1.0× 34 1.4× 36 2.0× 8 124

Countries citing papers authored by Tom Hofste

Since Specialization
Citations

This map shows the geographic impact of Tom Hofste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Hofste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Hofste more than expected).

Fields of papers citing papers by Tom Hofste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Hofste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Hofste. The network helps show where Tom Hofste may publish in the future.

Co-authorship network of co-authors of Tom Hofste

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Hofste. A scholar is included among the top collaborators of Tom Hofste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Hofste. Tom Hofste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bitter, Tessa J.J. de, Maartje J. Geerlings, Leonie I. Kroeze, et al.. (2025). Clinical utility of liquid biopsy next-generation sequencing for advanced non-small cell lung cancer in the Netherlands. Scientific Reports. 15(1). 30343–30343.
2.
Westra, Dineke, Eddy N. de Boer, Tom Hofste, et al.. (2024). Future of Dutch NGS-Based Newborn Screening: Exploring the Technical Possibilities and Assessment of a Variant Classification Strategy. International Journal of Neonatal Screening. 10(1). 20–20. 6 indexed citations
3.
Oud, Manon S., Dominique Smeets, Liliana Ramos, et al.. (2024). Innovative all‐in‐one exome sequencing strategy for diagnostic genetic testing in male infertility: Validation and 10‐month experience. Andrology. 13(5). 1078–1092. 2 indexed citations
4.
Post, Rachel S. van der, Janet R. Vos, Arjen R. Mensenkamp, et al.. (2024). Genomic instability in non–breast or ovarian malignancies of individuals with germline pathogenic variants in BRCA1/2. JNCI Journal of the National Cancer Institute. 116(12). 1904–1913.
5.
Tolmeijer, Sofie H., Sandra van Wilpe, Maartje J. Geerlings, et al.. (2023). Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer. European Urology Oncology. 7(2). 282–291. 10 indexed citations
6.
Geerlings, Maartje J., Daniel von Rhein, Sofie H. Tolmeijer, et al.. (2022). Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer. Cancers. 14(18). 4417–4417. 17 indexed citations
7.
Schieving, Jolanda, Helger G. Yntema, Maartje Pennings, et al.. (2022). Reanalysis of exome negative patients with rare disease: a pragmatic workflow for diagnostic applications. Genome Medicine. 14(1). 66–66. 25 indexed citations
8.
9.
Jonckheere, An I., Marije Hogeveen, Leo Nijtmans, et al.. (2009). A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy. BMJ Case Reports. 2009. bcr0720080504–bcr0720080504. 18 indexed citations
10.
Jonckheere, An I., Marije Hogeveen, Leo Nijtmans, et al.. (2007). A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy. Journal of Medical Genetics. 45(3). 129–133. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esmeralda Rodrigues Breakdown of academic impact, for papers by Masaki Wake Breakdown of academic impact, for papers by Aisha Al Shamsi Breakdown of academic impact, for papers by Matthias Kettwig Breakdown of academic impact, for papers by Ping Chun Wu Breakdown of academic impact, for papers by Anna Barbara Mancuso Breakdown of academic impact, for papers by Caroline Scholz Breakdown of academic impact, for papers by Yael Wilnai Breakdown of academic impact, for papers by Laura Benedetta Amato Breakdown of academic impact, for papers by Gudny A. Arnadottir
Rankless by CCL
2026